The latest closing stock price for Eiger BioPharmaceuticals as of April 10, 2024 is 1.73.
An investor who bought $1,000 worth of Eiger BioPharmaceuticals stock at the IPO in 2016 would have $-996 today, roughly -1 times their original investment - a -50.48% compound annual growth rate over 8 years.
The all-time high Eiger BioPharmaceuticals stock closing price was 691.20 on June 07, 2016.
The Eiger BioPharmaceuticals 52-week high stock price is 14.35, which is 729.5% above the current share price.
The Eiger BioPharmaceuticals 52-week low stock price is 1.10, which is 36.4% below the current share price.
The average Eiger BioPharmaceuticals stock price for the last 52 weeks is 7.38.
An investor who bought $1,000 worth of Eiger BioPharmaceuticals stock at the IPO in 2016 would have $-996 today, roughly -1 times their original investment - a -50.48% compound annual growth rate over 8 years.
The all-time high Eiger BioPharmaceuticals stock closing price was 691.20 on June 07, 2016.
The Eiger BioPharmaceuticals 52-week high stock price is 14.35, which is 729.5% above the current share price.
The Eiger BioPharmaceuticals 52-week low stock price is 1.10, which is 36.4% below the current share price.
The average Eiger BioPharmaceuticals stock price for the last 52 weeks is 7.38.